Review Timeline | CrossMark Policy | ClinMed Features
logo
International Journal of

Virology and AIDSISSN: 2469-567X

Early Online

 Open Access DOI:10.23937/2469-567X/1510096

Circulating Measles Virus Genotypes in Parts of North-eastern Nigeria (2019-2022)

Umar Abdullahi, Maryam Aminu, Ahmed Babangida Suleiman, Grace N.S. Kia, Nnaemeka Darlington Ndodo, Richard Ojedeleand and Luc Venance Kouakou

Article Type: Research Article | First Published: 2024/11/16

Measles is a highly contagious viral disease that remains a leading cause of morbidity and mortality in many developing countries. Caused by the measles virus (MeV), a single-stranded RNA virus, it exhibits genetic diversity based on the nucleoprotein gene, with 24 known genotypes. The World Health Organization AFRO region which includes Nigeria targeted the year 2020 as the year to eliminate measles. In 2021, Nigeria had the world's largest number of measles cases than any country: Over 10,000 ...

 Open Access DOI:10.23937/2469-567X/1510095

Virologic Efficacy of Recycling Tenofovir and Lamivudine/Emtricitabine in Second-Line Antiretroviral Treatment with Dolutegravir: A Non-Inferiority-Matched Cohort Study in Senegal

Bruce Shinga Wembulua, Daye KA, Viviane Marie Pierre Cisse, Ndeye Fatou Ngom, Ahmadou Mboup, Ibrahima Diao, Aminata Massaly, Kalilou Diallo, Mouhamadou Baila Diallo, Junior Latyr Diouf, Jonas Kombila, Moustapha Diop, Papa Samba BA, Noël Magloire Manga, Stanislas Okitotsho Wembonyama, Zacharie Kibendelwa Tsongo and Moussa Seydi

Article Type: Original Article | First Published: 2024/11/14

The World Health Organization (WHO) now recommends dolutegravir (DTG)-based regimens as the preferred option for first-line and second-line antiretroviral therapy (ART) for all people living with HIV (pwHIV). However, exposure to tenofovir (TDF) in first-line antiretroviral therapy (ART) could compromise its efficacy (K65r mutation). Our study aimed to assess whether recycling TDF and lamivudine or emtricitabine (XTC) with DTG as second line ART is non-inferior to optimized nucleotide reverse t...

 Open Access DOI:10.23937/2469-567X/1510094

Understanding Low Vaccine Uptake in African, Caribbean, and Black Populations Relative to Public Health in High-Income Countries: A Scoping Review Protocol

Josephine Etowa, Sheryl Beauchamp and Victoria Cole

Article Type: Original Research | First Published: 2024/03/21

Vaccination has significantly contributed to reducing once common and even deadly infectious diseases, yet vaccine hesitancy threatens the emergence of vaccine-preventable diseases. The COVID-19 pandemic has caused the need for the largest mass vaccination campaign ever undertaken to date; however, African, Caribbean, and Black (ACB) populations have shown both a disproportionately high degree of negative impacts from the pandemic and the lowest willingness to become vaccinated. Low vaccination ...

 Open Access DOI:10.23937/2469-567X/1510093

Factors Associated with HIV/Tuberculosis Coinfection among People Living with HIV after Initiation of Antiretroviral Treatment in Lingwala Health Zone from 2021 To 2023

Jean Claude Mikobi Maleshila, Espérant Ntambue Malu, Fabrice Sewolo, Tacite Kpanya Mazoba and Jean Nyandwe Kyloka

Article Type: Original Research | First Published: 2024/03/08

Around 8% of incident cases of tuberculosis (TB) were reported among people living with HIV worldwide in 2022. Tuberculosis is the leading cause of death among people living with HIV. Africa accounts for the majority of co-infection episodes, with over 50% of cases in some parts of southern Africa. In the Democratic Republic of Congo (DRC), around 9% of persons living with HIV (PLHIV) develop TB and 11% of TB patients are infected with HIV. The DRC is one of the 30 countries in the world bearing...

Volume 11
Issue 1